U.S. government report on “notorious markets” known for counterfeiting and other violations of intellectual property says ...
Protein powders may contain high levels of lead and cadmium, with chocolate-flavored and plant-based products testing at the ...
It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other ...
Clinical trials are underway in Colorado for a new drug that could extend a dog’s lifespan. Loyal, a San Francisco-based ...
But that’s not always how serious illness plays out. Children who need to be on ventilators, have tracheostomies or ...
The FDA wrapped up 2024 with 50 new drug approvals, clearing a wave of long-awaited treatments. Meanwhile, Transcarent will ...
Exelixis said it was notified by the Food and Drug Administration that its treatment for advanced pancreatic neuroendocrine tumors and advanced extra-pancreatic will not be discussed at a meeting.
In an interview, outgoing FDA commissioner Robert Califf was wary of the Trump administration but unapologetic about ...
The biotherapeutics company said the treatment, LYT-200, is being evaluated in two ongoing clinical trials. It was previously granted orphan drug designation for the treatment of acute myeloid ...
The FDA wants the developers of medical devices that rely on AI to disclose more detail about how their devices were ...
Red dye No. 3, used in drinks and snacks, could be banned by the U.S. Food and Drug Administration in the next few weeks, the ...